Within the past year, Dr Daniel Javitt has served as a consultant to Sepracor, AstraZeneca, Pfizer, Cypress Bioscience, Merck, Sunovion, Eli Lilly, and BMS, and has received research support from Pfizer, Roche, and Jazz Pharmaceuticals
Is an OTC antacid or acid reducer appropriate for me
Preclinical and early-phase clinical studies suggest that certain natural supplements may modulate therapeutic response and influence treatment-related toxicity
ADORA2b genetic variants are prevalent and associate with increased red blood cell hemolysis We analyzed 879,000 SNP in the REDS cohort focusing on ADORA2B
Improves skin hydration , helping to plump up your skin from within, reducing the appearance of fine lines and wrinkles
Hypoglycaemia (low blood glucose) can occur, particularly when Ozempic is used in combination with insulin or sulfonylureas